Years of research
In collaboration with the Swiss Federal Institute of Technology de Lausanne (EPFL)
Our mission is to redefine how we age
Who we are
Timeline is a Swiss-born longevity brand founded by scientists, doctors, and innovators on a mission to extend healthspan through clinically proven science. At the core is Mitopure®, our proprietary Urolithin A, shown to improve mitochondrial function—foundational for living longer and healthier.
We’re not built on hype, but on human clinical evidence—with over 80 patents and five gold-standard clinical trials. Timeline is setting a new standard in longevity.
We’re not built on hype, but on human clinical evidence—with over 80 patents and five gold-standard clinical trials. Timeline is setting a new standard in longevity.
Human clinical trials
Completed and ongoing gold-standard clinical trials on nutrition and skincare involving over 900 participants
Studies on Urolithin A
Scientists have extensively explored Urolithin A’s effectiveness on health and patented the bioactive into Mitopure®
Patents
Our proprietary ingredient Mitopure® is protected under 80 patents
Built on science, guided by experts
“What makes Timeline so unique compared to all the other companies out there is really our deep dedication to science that we employ in the development of all of our products.”
Chris Rinsch, PhDCo-founder & President
“My vision is that timeline becomes one of those brands that is trusted because there's real science behind. To try to say to the consumer, they will take it, you're going to have a healthier aging process so that you can enjoy life longer.”
Dr. Patrick Aebischer, MDChairman, Scientific Advisory Board
Good things take time
Named a Top 40 Global Finalist in the $101M XPRIZE Healthspan Competition, recognizing Timeline as a world leader in clinically proven longevity interventions.
Over 80 global patents granted for Urolithin A and Mitopure®.
Topical skincare line powered by Mitopure® launched with proven benefits for firmness and radiance.
Clinically validated the benefits on energy, strength, and endurance at higher 1000mg dose.
Elite athlete study: Better muscle endurance and recovery in elite athletes, 4 weeks 1000mg dose.
Landmark clinical trial showed up to 12% muscle strength improvement in older adults.
Mitopure delivers 6X more Urolithin A than a 8oz of pomegranate juice in a separate clinical study.
Launched Mitopure® — the first and only clinically tested Urolithin A supplement — in the U.S. market.
Clinical research program launched on topical application of Mitopure for skin longevity benefits
Discovered that the key difference between healthy, strong aging adults and those who are frail is the quality of the mitochondria in their muscles.
Achieved FDA GRAS (Generally Recognized as Safe) status for Mitopure® following a rigorous, direct review by the agency—unlike the self-GRAS pathway used by most supplement companies.
Launched the first-ever human clinical trial of Urolithin A.
Breakthrough peer reviewed preclinical studies show Urolithin A improves mitochondrial function and muscle health.
Developed Mitopure®, the first highly pure, bioavailable form of Urolithin A designed specifically for safe human use.
Identified Urolithin A: a powerful postbiotic that reactivates mitophagy — the body's cellular recycling process essential for healthy aging.
Zeroed in on natural compounds in pomegranates, but with a rigorous scientific lens to go far beyond traditional superfood claims.
Began pioneering research on mitochondria — the energy engines of our cells — and how their decline drives aging.
Founded by MDs and PhDs at EPFL (Swiss Federal Institute of Technology) with a mission to target aging at its root through cutting-edge science.
Meet the minds guiding our journey toward a healthier future
We are supported by the knowledge and guidance of an accomplished group of scientific and clinical advisors with expertise spanning microbiome science, genomics, metabolomics, gastroenterology, immunology, nutrition, and human clinical research.
Our leadership
Brian RayCEO+
Brian Ray is the CEO of Timeline Longevity Inc., a company dedicated to advancing human healthspan through innovative nutritional solutions. With a passion for science-backed wellness, Brian leads the company in developing breakthrough products that promote healthy aging. With over 20 years of experience in the health and wellness industry, he combines his expertise in business strategy with a commitment to improving quality of life, driving Timeline's mission to help people live healthier, longer lives.
Chris Rinsch, PhDCo-founder & President+
Chris Rinsch is co-founder and President of Timeline Longevity. For more than two decades, he has been an innovator in the life sciences arena. Before founding Timeline in 2007, Rinsch worked in venture capital investing in pioneering life sciences companies in the nutrition space and in biotechnology developing cell-based therapies at the Swiss biotech company ISOTIS SA, formerly Modex SA. Rinsch has authored original publications in leading scientific journals, including Nature Medicine, Nature Metabolism, Jama Open, Cell Reports Medicine and others, for his research on Urolithin A, mitochondrial health, muscle function, and joint health. He is also an inventor on several internationally filed and granted patents. Rinsch holds an MBA from INSEAD, France, a PhD in Cell and Molecular Biology from the University of Lausanne, a Master of Science in Biomedical Engineering from U.T. Southwestern Medical Center, and a Bachelor of Science in Engineering from Harvey Mudd College.
Dr. Anurag SinghChief Medical Officer+
Anurag Singh is the Chief Medical Officer at Timeline, a global leader in longevity science, developing the next generation advanced nutritional and skincare products targeting improvements in mitochondrial and cellular health. With a M.D. in internal medicine and a Ph.D. in immunology, his experience includes work at top consumer health (Nestlé, Nestlé Health Science) and startups companies (Amazentis/Timeline). He’s authored >40 articles for top science journals, been awarded >15 patents and has designed and led >50 randomized clinical trials. His research over the past decade across multiple clinical trials on the postbiotic Urolithin A and its health benefits has led to the launch of multiple consumer products.
Federico LunaChief Marketing Officer+
Federico Luna is the Chief Marketing Officer at Timeline Longevity, where he spearheads the company's marketing strategy and brand development. With a deep understanding of consumer behavior and a passion for health and wellness, Federico brings over 15 years of experience in building successful brands in the nutrition and lifestyle sectors. His innovative approach to marketing focuses on educating and engaging audiences about the benefits of healthy aging, helping to drive Timeline’s mission forward.
Erik SchmittChief Financial Officer+
Erik Schmitt is Chief Financial Officer at Timeline Longevity. He has 30 years of experience as a Finance & Accounting professional with over 20 years of experience growing brands in the nutritional supplement category . At Timeline, Erik is committed to working with the leadership team to evolve the business from start-up to full-scale commercial leader in the Longevity supplement and skin care categories. His role as CFO is focused on building strong systems and controls to support the growth and financial performance of Timeline Longevity.
Scientific and clinical advisors
Dr. Johan Auwerx MD, PhDScientific Advisor+
Professor. Johan Auwerx directs the Laboratory for Integrated and Systems Physiology at École Polytechnique Fédérale (EPFL) in Lausanne, Switzerland, where he studies the mechanisms that control how metabolisms are controlled and the factors that make them more or less effective. Focusing on longevity, his team is using multiple animal species to test a specific compound, Urolithin A, which could potentially restore much-needed muscle strength and energy to people as they age. Prof. Auwerx is a scientific advisor to Amazentis.
Dr. Patrick Aebischer, MDChairman, Scientific Advisory Board+
Professor Patrick Aebischer, chairman and co-founder of Amazentis, is a medical doctor, neuroscientist and longtime researcher. He has held distinguished positions in his home country of Switzerland, as President of the École Polytechnique Fédérale de Lausanne (EPFL) and in the United States at Brown University in Providence.
Dr. Carmen Sandi, PhDScientific Advisor+
Director, Brain and Mind Institute and Professor at the EPFL, Lausanne, Switzerland | Neurobehavioral science and stress related brain disorders
Eric Verdin, MDCEO Buck Institute for Research on Aging, Scientific Advisor+
Dr. Eric M. Verdin, is a leading authority on aging research and metabolic science, has been at the helm of the Buck Institute for Research on Aging as its President and CEO since 2016. Specializing in the intricate relationship between diet, molecular biology, and age-related diseases, Dr. Verdin has contributed extensively to the field with over 210 scholarly articles and a portfolio of 15+ patents. As a professor and researcher, his work delves into understanding the proteins and molecules that influence the aging process and associated health conditions.